<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35163252</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Emerging Connections between Nuclear Pore Complex Homeostasis and ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1329</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23031329</ELocationID><Abstract><AbstractText>Developing effective treatments for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) requires understanding of the underlying pathomechanisms that contribute to the motor neuron loss that defines the disease. As it causes the largest fraction of familial ALS cases, considerable effort has focused on hexanucleotide repeat expansions in the <i>C9ORF72</i> gene, which encode toxic repeat RNA and dipeptide repeat (DPR) proteins. Both the repeat RNA and DPRs interact with and perturb multiple elements of the nuclear transport machinery, including shuttling nuclear transport receptors, the Ran GTPase and the nucleoporin proteins (nups) that build the nuclear pore complex (NPC). Here, we consider recent work that describes changes to the molecular composition of the NPC in <i>C9ORF72</i> model and patient neurons in the context of quality control mechanisms that function at the nuclear envelope (NE). For example, changes to NPC structure may be caused by the dysregulation of a conserved NE surveillance pathway mediated by the endosomal sorting complexes required for the transport protein, CHMP7. Thus, these studies are introducing NE and NPC quality control pathways as key elements in a pathological cascade that leads to <i>C9ORF72</i> ALS, opening entirely new experimental avenues and possibilities for targeted therapeutic intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Sunandini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5386-0934</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Yale School of Medicine, 295 Congress Ave, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lusk</LastName><ForeName>C Patrick</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0003-4703-0533</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Yale School of Medicine, 295 Congress Ave, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS122236</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS122236</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9ORF72 ALS</Keyword><Keyword MajorTopicYN="N">CHMP7</Keyword><Keyword MajorTopicYN="N">ESCRT</Keyword><Keyword MajorTopicYN="N">NPC injury</Keyword><Keyword MajorTopicYN="N">POM121</Keyword><Keyword MajorTopicYN="N">nuclear quality control</Keyword><Keyword MajorTopicYN="N">nuclear transport</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35163252</ArticleId><ArticleId IdType="pmc">PMC8835831</ArticleId><ArticleId IdType="doi">10.3390/ijms23031329</ArticleId><ArticleId IdType="pii">ijms23031329</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feigin V.L., Nichols E., Alam T., Bannick M.S., Beghi E., Blake N., Culpepper W.J., Dorsey E.R., Elbaz A., Ellenbogen R.G., et al. Global, regional, and national burden of neurological disorders, 1990&#x2013;2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459&#x2013;480. doi: 10.1016/S1474-4422(18)30499-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30499-X</ArticleId><ArticleId IdType="pmc">PMC6459001</ArticleId><ArticleId IdType="pubmed">30879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio G.D., Voltz R., Miller R.G. Palliative Care in Amyotrophic Lateral Sclerosis. Neurol. Clin. 2001;19:829&#x2013;847. doi: 10.1016/S0733-8619(05)70049-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0733-8619(05)70049-9</ArticleId><ArticleId IdType="pubmed">11854102</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris S.P., Likanje M.N., Andrews J.A. Amyotrophic lateral sclerosis: Update on clinical management. Curr. Opin. Neurol. 2020;33:641&#x2013;648. doi: 10.1097/WCO.0000000000000864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000864</ArticleId><ArticleId IdType="pubmed">32868602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdmanis P.N., Rouleau G.A. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144&#x2013;152. doi: 10.1212/01.wnl.0000296811.19811.db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000296811.19811.db</ArticleId><ArticleId IdType="pubmed">18180444</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Zaepfel B.L., Hayes L., Fitchman B., Salzberg Y., Luo E.C., Bowen K., Trost H., Aigner S., Rigo F., et al. G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD. Neuron. 2020;107:1124&#x2013;1140 e1111. doi: 10.1016/j.neuron.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Toro A., TG S., Gao J., Chalk J., Oskarsson B., Zhang K. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD. Mol. Neurodegener. 2020;15:34. doi: 10.1186/s13024-020-00383-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00383-7</ArticleId><ArticleId IdType="pmc">PMC7282082</ArticleId><ArticleId IdType="pubmed">32513219</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F., Perez-Berlanga M., Hartl F.U., Hipp M.S. Multiple pathways of toxicity induced by C9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model. eLife. 2021;10:e62718. doi: 10.7554/eLife.62718.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.62718</ArticleId><ArticleId IdType="pmc">PMC8221807</ArticleId><ArticleId IdType="pubmed">34161229</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S., Rabichow B.E., Sattler R. The Hitchhiker&#x2019;s Guide to Nucleocytoplasmic Trafficking in Neurodegeneration. Neurochem. Res. 2020;45:1306&#x2013;1327. doi: 10.1007/s11064-020-02989-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-02989-1</ArticleId><ArticleId IdType="pubmed">32086712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S., Dormann D. Nucleocytoplasmic transport defects in neurodegeneration&#x2014;Cause or consequence? Semin. Cell Dev. Biol. 2020;99:151&#x2013;162. doi: 10.1016/j.semcdb.2019.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.020</ArticleId><ArticleId IdType="pubmed">31152789</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Khalil B., Smith C.L., Rossoll W. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol. Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Van Den Bosch L. The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:12175. doi: 10.3390/ijms222212175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212175</ArticleId><ArticleId IdType="pmc">PMC8620263</ArticleId><ArticleId IdType="pubmed">34830069</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmelink M.F.W., Steen A., Veenhoff L.M. Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease-The Example of C9orf72 ALS. Int. J. Mol. Sci. 2021;22:9217. doi: 10.3390/ijms22179217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179217</ArticleId><ArticleId IdType="pmc">PMC8431710</ArticleId><ArticleId IdType="pubmed">34502125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Segura L.M., Lafarga M., Berciano M.T., Hernandez P., Andres M.A. Distribution of nuclear pores and chromatin organization in neurons and glial cells of the rat cerebellar cortex. J. Comp. Neurol. 1989;290:440&#x2013;450. doi: 10.1002/cne.902900311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.902900311</ArticleId><ArticleId IdType="pubmed">2592622</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama B.H., Savas J.N., Park S.K., Harris M.S., Ingolia N.T., Yates J.R., 3rd, Hetzer M.W. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell. 2013;154:971&#x2013;982. doi: 10.1016/j.cell.2013.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.037</ArticleId><ArticleId IdType="pmc">PMC3788602</ArticleId><ArticleId IdType="pubmed">23993091</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda T., Hsu J.Y., Linker S.B., Hu L., Schafer S.T., Mertens J., Jacinto F.V., Hetzer M.W., Gage F.H. Nup153 Interacts with Sox2 to Enable Bimodal Gene Regulation and Maintenance of Neural Progenitor Cells. Cell Stem Cell. 2017;21:618&#x2013;634 e617. doi: 10.1016/j.stem.2017.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2017.08.012</ArticleId><ArticleId IdType="pubmed">28919367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampoelz B., Andres-Pons A., Kastritis P., Beck M. Structure and Assembly of the Nuclear Pore Complex. Ann. Rev. Biophys. 2019;48:515&#x2013;536. doi: 10.1146/annurev-biophys-052118-115308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-052118-115308</ArticleId><ArticleId IdType="pubmed">30943044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wente S.R., Rout M.P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2010;2:a000562. doi: 10.1101/cshperspect.a000562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000562</ArticleId><ArticleId IdType="pmc">PMC2944363</ArticleId><ArticleId IdType="pubmed">20630994</ArticleId></ArticleIdList></Reference><Reference><Citation>Paci G., Caria J., Lemke E.A. Cargo transport through the nuclear pore complex at a glance. J. Cell Sci. 2021;134:jcs247874. doi: 10.1242/jcs.247874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.247874</ArticleId><ArticleId IdType="pubmed">33495357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Taylor J.P. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron. 2017;96:285&#x2013;297. doi: 10.1016/j.neuron.2017.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.029</ArticleId><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitetto G., Di Fonzo A. Nucleo-cytoplasmic transport defects and protein aggregates in neurodegeneration. Transl. Neurodegener. 2020;9:25. doi: 10.1186/s40035-020-00205-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00205-2</ArticleId><ArticleId IdType="pmc">PMC7333321</ArticleId><ArticleId IdType="pubmed">32616075</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.A., Smikle R., Reid M.J., Mizielinska S. Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD. Front. Cell Neurosci. 2021;15:664151. doi: 10.3389/fncel.2021.664151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.664151</ArticleId><ArticleId IdType="pmc">PMC8096919</ArticleId><ArticleId IdType="pubmed">33967699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan A.C., Leung A.K.L. RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD. In: Yeo G.W., editor. RNA Processing: Disease and Genome-Wide Probing. Springer International Publishing; Cham, Switzerland: 2016. pp. 263&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5247449</ArticleId><ArticleId IdType="pubmed">27256390</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T., Ali R., Jiou J., Fung H.Y.J., Burke K.A., Kim S.J., Lin Y., Peeples W.B., Saltzberg D., Soniat M., et al. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. Cell. 2018;173:693&#x2013;705 e622. doi: 10.1016/j.cell.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Springhower C.E., Rosen M.K., Chook Y.M. Karyopherins and condensates. Curr. Opin. Cell Biol. 2020;64:112&#x2013;123. doi: 10.1016/j.ceb.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7371519</ArticleId><ArticleId IdType="pubmed">32474299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.C., Kumar M.S., Ramesh N., Anderson E.N., Nguyen A.T., Kim B., Cheung S., McDonough J.A., Skarnes W.C., Lopez-Gonzalez R., et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat. Neurosci. 2021;24:1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo M.A., Raices M., Panowski S.H., Hetzer M.W. Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell. 2009;136:284&#x2013;295. doi: 10.1016/j.cell.2008.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.11.037</ArticleId><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>Savas J.N., Toyama B.H., Xu T., Yates J.R., 3rd, Hetzer M.W. Extremely long-lived nuclear pore proteins in the rat brain. Science. 2012;335:942. doi: 10.1126/science.1217421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1217421</ArticleId><ArticleId IdType="pmc">PMC3296478</ArticleId><ArticleId IdType="pubmed">22300851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sydor A.M., Czymmek K.J., Puchner E.M., Mennella V. Super-Resolution Microscopy: From Single Molecules to Supramolecular Assemblies. Trends Cell Biol. 2015;25:730&#x2013;748. doi: 10.1016/j.tcb.2015.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.10.004</ArticleId><ArticleId IdType="pubmed">26546293</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermelleh L., Carlton P.M., Haase S., Shao L., Winoto L., Kner P., Burke B., Cardoso M.C., Agard D.A., Gustafsson M.G.L., et al. Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science. 2008;320:1332&#x2013;1336. doi: 10.1126/science.1156947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1156947</ArticleId><ArticleId IdType="pmc">PMC2916659</ArticleId><ArticleId IdType="pubmed">18535242</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N.V., Zaepfel B.L., Dickson D.W., Rigo F., Bennett F., Lusk C.P., Rothstein J.D. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 2021;13:eabe1923. doi: 10.1126/scitranslmed.abe1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe1923</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Grima J.C., Rothstein J.D., Lloyd T.E. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD. Nucleus. 2016;7:132&#x2013;137. doi: 10.1080/19491034.2016.1172152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19491034.2016.1172152</ArticleId><ArticleId IdType="pmc">PMC4916865</ArticleId><ArticleId IdType="pubmed">27116041</ArticleId></ArticleIdList></Reference><Reference><Citation>Regmi S.G., Lee H., Kaufhold R., Fichtman B., Chen S., Aksenova V., Turcotte E., Harel A., Arnaoutov A., Dasso M. The nuclear pore complex consists of two independent scaffolds. BioRixv. 2020 doi: 10.1101/2020.11.13.381947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.13.381947</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksenova V., Smith A., Lee H., Bhat P., Esnault C., Chen S., Iben J., Kaufhold R., Yau K.C., Echeverria C., et al. Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway. Nat. Commun. 2020;11:4577. doi: 10.1038/s41467-020-18266-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18266-2</ArticleId><ArticleId IdType="pmc">PMC7486939</ArticleId><ArticleId IdType="pubmed">32917881</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller A.P., Wojtynek M., Mankus D., Tatli M., Kronenberg-Tenga R., Regmi S.G., Dip P.V., Lytton-Jean A.K.R., Brignole E.J., Dasso M., et al. The cellular environment shapes the nuclear pore complex architecture. Nature. 2021;598:667&#x2013;671. doi: 10.1038/s41586-021-03985-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03985-3</ArticleId><ArticleId IdType="pmc">PMC8550940</ArticleId><ArticleId IdType="pubmed">34646014</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.M., Mansfeld J., Capitanio J., Kutay U., Wozniak R.W. Pom121 links two essential subcomplexes of the nuclear pore complex core to the membrane. J. Cell Biol. 2010;191:505&#x2013;521. doi: 10.1083/jcb.201007098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201007098</ArticleId><ArticleId IdType="pmc">PMC3003318</ArticleId><ArticleId IdType="pubmed">20974814</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucet C.M., Talamas J.A., Hetzer M.W. Cell cycle-dependent differences in nuclear pore complex assembly in metazoa. Cell. 2010;141:1030&#x2013;1041. doi: 10.1016/j.cell.2010.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.04.036</ArticleId><ArticleId IdType="pmc">PMC2887351</ArticleId><ArticleId IdType="pubmed">20550937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C., Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818&#x2013;822. doi: 10.1126/science.aax3769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3769</ArticleId><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrtash A.B., Hochstrasser M. Ubiquitin-dependent protein degradation at the endoplasmic reticulum and nuclear envelope. Semin. Cell Dev. Biol. 2019;93:111&#x2013;124. doi: 10.1016/j.semcdb.2018.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2018.09.013</ArticleId><ArticleId IdType="pmc">PMC6748311</ArticleId><ArticleId IdType="pubmed">30278225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Chen Y., Tooze S.A. Autophagy pathway: Cellular and molecular mechanisms. Autophagy. 2018;14:207&#x2013;215. doi: 10.1080/15548627.2017.1378838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1378838</ArticleId><ArticleId IdType="pmc">PMC5902171</ArticleId><ArticleId IdType="pubmed">28933638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Gendron T.F., Grima J.C., Sasaguri H., Jansen-West K., Xu Y.F., Katzman R.B., Gass J., Murray M.E., Shinohara M., et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruz C., Alcantud J.L., Vives Montero F., Duran R., Bandres-Ciga S. Proteotoxicity and Neurodegenerative Diseases. Int. J. Mol. Sci. 2020;21:5646. doi: 10.3390/ijms21165646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165646</ArticleId><ArticleId IdType="pmc">PMC7460676</ArticleId><ArticleId IdType="pubmed">32781742</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., D&#x2019;Amico R., Zucchi E., Gessani A., Fini N., Fasano A., Caponnetto C., Chio A., Dalla Bella E., Lunetta C., et al. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) Medicine. 2018;97:e11119. doi: 10.1097/MD.0000000000011119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011119</ArticleId><ArticleId IdType="pmc">PMC6024184</ArticleId><ArticleId IdType="pubmed">29901635</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M., Hochstrasser M. Spatially regulated ubiquitin ligation by an ER/nuclear membrane ligase. Nature. 2006;443:827&#x2013;831. doi: 10.1038/nature05170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05170</ArticleId><ArticleId IdType="pubmed">17051211</ArticleId></ArticleIdList></Reference><Reference><Citation>Foresti O., Rodriguez-Vaello V., Funaya C., Carvalho P. Quality control of inner nuclear membrane proteins by the Asi complex. Science. 2014;346:751&#x2013;755. doi: 10.1126/science.1255638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1255638</ArticleId><ArticleId IdType="pubmed">25236469</ArticleId></ArticleIdList></Reference><Reference><Citation>Khmelinskii A., Blaszczak E., Pantazopoulou M., Fischer B., Omnus D.J., Le Dez G., Brossard A., Gunnarsson A., Barry J.D., Meurer M., et al. Protein quality control at the inner nuclear membrane. Nature. 2014;516:410&#x2013;413. doi: 10.1038/nature14096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14096</ArticleId><ArticleId IdType="pmc">PMC4493439</ArticleId><ArticleId IdType="pubmed">25519137</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch B.A., Jin H., Tomko R.J., Jr., Yu H.G. The anaphase-promoting complex regulates the degradation of the inner nuclear membrane protein Mps3. J. Cell Biol. 2019;218:839&#x2013;854. doi: 10.1083/jcb.201808024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201808024</ArticleId><ArticleId IdType="pmc">PMC6400550</ArticleId><ArticleId IdType="pubmed">30737264</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai P.L., Zhao C., Turner E., Schlieker C. The Lamin B receptor is essential for cholesterol synthesis and perturbed by disease-causing mutations. eLife. 2016;5:e16011. doi: 10.7554/eLife.16011.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.16011</ArticleId><ArticleId IdType="pmc">PMC4951196</ArticleId><ArticleId IdType="pubmed">27336722</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert S., Schaffer M., Beck F., Mosalaganti S., Asano S., Thomas H.F., Plitzko J.M., Beck M., Baumeister W., Engel B.D. Proteasomes tether to two distinct sites at the nuclear pore complex. Proc. Natl. Acad. Sci. USA. 2017;114:13726&#x2013;13731. doi: 10.1073/pnas.1716305114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1716305114</ArticleId><ArticleId IdType="pmc">PMC5748218</ArticleId><ArticleId IdType="pubmed">29229809</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Yanagida M. Regulation of nuclear proteasome by Rhp6/Ubc2 through ubiquitination and destruction of the sensor and anchor Cut8. Cell. 2005;122:393&#x2013;405. doi: 10.1016/j.cell.2005.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.05.023</ArticleId><ArticleId IdType="pubmed">16096059</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Tonthat N.K., Glover T., Xu W., Koonin E.V., Yanagida M., Schumacher M.A. Implications for proteasome nuclear localization revealed by the structure of the nuclear proteasome tether protein Cut8. Proc. Natl. Acad. Sci. USA. 2011;108:16950&#x2013;16955. doi: 10.1073/pnas.1103617108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103617108</ArticleId><ArticleId IdType="pmc">PMC3193221</ArticleId><ArticleId IdType="pubmed">21976488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Romero L., Chuang S.M., Tournier V., Joshi K.K., Lee J.A., Kovvali G., Madura K. Sts1 plays a key role in targeting proteasomes to the nucleus. J. Biol. Chem. 2011;286:3104&#x2013;3118. doi: 10.1074/jbc.M110.135863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.135863</ArticleId><ArticleId IdType="pmc">PMC3024803</ArticleId><ArticleId IdType="pubmed">21075847</ArticleId></ArticleIdList></Reference><Reference><Citation>Niepel M., Molloy K.R., Williams R., Farr J.C., Meinema A.C., Vecchietti N., Cristea I.M., Chait B.T., Rout M.P., Strambio-De-Castillia C. The nuclear basket proteins Mlp1p and Mlp2p are part of a dynamic interactome including Esc1p and the proteasome. Mol. Biol. Cell. 2013;24:3920&#x2013;3938. doi: 10.1091/mbc.e13-07-0412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e13-07-0412</ArticleId><ArticleId IdType="pmc">PMC3861087</ArticleId><ArticleId IdType="pubmed">24152732</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida M., Hinterndorfer M., Brunner H., Grishkovskaya I., Singh K., Schleiffer A., Jude J., Deswal S., Kalis R., Vunjak M., et al. AKIRIN2 controls the nuclear import of proteasomes in vertebrates. Nature. 2021;599:491&#x2013;496. doi: 10.1038/s41586-021-04035-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04035-8</ArticleId><ArticleId IdType="pubmed">34711951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S., Mannino P.J., Thaller D.J., Ader N.R., King M.C., Melia T.J., Lusk C.P. Atg39 selectively captures inner nuclear membrane into lumenal vesicles for delivery to the autophagosome. J. Cell Biol. 2021;220:e202103030. doi: 10.1083/jcb.202103030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202103030</ArticleId><ArticleId IdType="pmc">PMC8575018</ArticleId><ArticleId IdType="pubmed">34714326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochida K., Otani T., Katsumata Y., Kirisako H., Kakuta C., Kotani T., Nakatogawa H. Atg39 links and deforms the outer and inner nuclear membranes in selective autophagy of the nucleus. BioRixv. 2021 doi: 10.1083/jcb.202103178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202103178</ArticleId><ArticleId IdType="pmc">PMC8789198</ArticleId><ArticleId IdType="pubmed">35061008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.W., Wilfling F., Ronchi P., Allegretti M., Mosalaganti S., Jentsch S., Beck M., Pfander B. Selective autophagy degrades nuclear pore complexes. Nat. Cell Biol. 2020;22:159&#x2013;166. doi: 10.1038/s41556-019-0459-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0459-2</ArticleId><ArticleId IdType="pubmed">32029894</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomioka Y., Kotani T., Kirisako H., Oikawa Y., Kimura Y., Hirano H., Ohsumi Y., Nakatogawa H. TORC1 inactivation stimulates autophagy of nucleoporin and nuclear pore complexes. J. Cell Biol. 2020;219:e201910063. doi: 10.1083/jcb.201910063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201910063</ArticleId><ArticleId IdType="pmc">PMC7337488</ArticleId><ArticleId IdType="pubmed">32453403</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegretti M., Zimmerli C.E., Rantos V., Wilfling F., Ronchi P., Fung H.K.H., Lee C.W., Hagen W., Turonova B., Karius K., et al. In-cell architecture of the nuclear pore and snapshots of its turnover. Nature. 2020;586:796&#x2013;800. doi: 10.1038/s41586-020-2670-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2670-5</ArticleId><ArticleId IdType="pubmed">32879490</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama B.H., Arrojo E.D.R., Lev-Ram V., Ramachandra R., Deerinck T.J., Lechene C., Ellisman M.H., Hetzer M.W. Visualization of long-lived proteins reveals age mosaicism within nuclei of postmitotic cells. J. Cell Biol. 2019;218:433&#x2013;444. doi: 10.1083/jcb.201809123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201809123</ArticleId><ArticleId IdType="pmc">PMC6363465</ArticleId><ArticleId IdType="pubmed">30552100</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough J., Frost A., Sundquist W.I. Structures, functions, and dynamics of ESCRT-III/Vps4 membrane remodeling and fission complexes. Ann. Rev. Cell Dev. Biol. 2018;34:85&#x2013;109. doi: 10.1146/annurev-cellbio-100616-060600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100616-060600</ArticleId><ArticleId IdType="pmc">PMC6241870</ArticleId><ArticleId IdType="pubmed">30095293</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster B.M., Colombi P., Jager J., Lusk C.P. Surveillance of nuclear pore complex assembly by ESCRT-III/Vps4. Cell. 2014;159:388&#x2013;401. doi: 10.1016/j.cell.2014.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.012</ArticleId><ArticleId IdType="pmc">PMC4194032</ArticleId><ArticleId IdType="pubmed">25303532</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster B.M., Thaller D.J., Jager J., Ochmann S.E., Borah S., Lusk C.P. Chm7 and Heh1 collaborate to link nuclear pore complex quality control with nuclear envelope sealing. EMBO J. 2016;35:2447&#x2013;2467. doi: 10.15252/embj.201694574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694574</ArticleId><ArticleId IdType="pmc">PMC5109239</ArticleId><ArticleId IdType="pubmed">27733427</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaller D.J., Allegretti M., Borah S., Ronchi P., Beck M., Lusk C.P. An ESCRT-LEM protein surveillance system is poised to directly monitor the nuclear envelope and nuclear transport system. eLife. 2019;8:e45284. doi: 10.7554/eLife.45284.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45284</ArticleId><ArticleId IdType="pmc">PMC6461442</ArticleId><ArticleId IdType="pubmed">30942170</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Urwin H., Engelborghs S., Bruyland M., Vandenberghe R., Dermaut B., De Pooter T., Peeters K., Santens P., De Deyn P.P., et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 2008;17:313&#x2013;322. doi: 10.1093/hmg/ddm309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm309</ArticleId><ArticleId IdType="pubmed">17956895</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Vlam L., van Es M.A., van der Pol W.L., Hennekam E.A., Dooijes D., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., et al. Genetic overlap between apparently sporadic motor neuron diseases. PLoS ONE. 2012;7:e48983. doi: 10.1371/journal.pone.0048983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048983</ArticleId><ArticleId IdType="pmc">PMC3498376</ArticleId><ArticleId IdType="pubmed">23155438</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 2005;37:806&#x2013;808. doi: 10.1038/ng1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Narain P., Pandey A., Gupta S., Gomes J., Bhatia R., Vivekanandan P. Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;71:265-e9. doi: 10.1016/j.neurobiolaging.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.05.012</ArticleId><ArticleId IdType="pubmed">29895397</ArticleId></ArticleIdList></Reference><Reference><Citation>Momeni P., Rogaeva E., Van Deerlin V., Yuan W., Grafman J., Tierney M., Huey E., Bell J., Morris C.M., Kalaria R.N., et al. Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener. Dis. 2006;3:129&#x2013;133. doi: 10.1159/000094771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000094771</ArticleId><ArticleId IdType="pubmed">16954699</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., Hollinger H.C., Hartley J.A., Brockington A., Burness C.E., et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS) PLoS ONE. 2010;5:e9872. doi: 10.1371/journal.pone.0009872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009872</ArticleId><ArticleId IdType="pmc">PMC2844426</ArticleId><ArticleId IdType="pubmed">20352044</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Devine H., Patani R., La Spada A.R., Hanna M.G., Greensmith L. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci. Rep. 2019;9:3539. doi: 10.1038/s41598-019-40118-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40118-3</ArticleId><ArticleId IdType="pmc">PMC6401132</ArticleId><ArticleId IdType="pubmed">30837566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusk C.P., Ader N.R. CHMPions of repair: Emerging perspectives on sensing and repairing the nuclear envelope barrier. Curr. Opin. Cell Biol. 2020;64:25&#x2013;33. doi: 10.1016/j.ceb.2020.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2020.01.011</ArticleId><ArticleId IdType="pmc">PMC7371540</ArticleId><ArticleId IdType="pubmed">32105978</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri M., Schultz S.W., Bellanger A., Jones C.M., Petersen L.I., Raiborg C., Skarpen E., Pedurupillay C.R.J., Kjos I., Kip E., et al. Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation. Nat. Cell Biol. 2020;22:856&#x2013;867. doi: 10.1038/s41556-020-0537-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-020-0537-5</ArticleId><ArticleId IdType="pubmed">32601372</ArticleId></ArticleIdList></Reference><Reference><Citation>von Appen A., LaJoie D., Johnson I.E., Trnka M.J., Pick S.M., Burlingame A.L., Ullman K.S., Frost A. LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation. Nature. 2020;582:115&#x2013;118. doi: 10.1038/s41586-020-2232-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2232-x</ArticleId><ArticleId IdType="pmc">PMC7321842</ArticleId><ArticleId IdType="pubmed">32494070</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Rothstein J.D. The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei. Acta Neuropathol. Commun. 2021;9:127. doi: 10.1186/s40478-021-01228-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01228-0</ArticleId><ArticleId IdType="pmc">PMC8287756</ArticleId><ArticleId IdType="pubmed">34281622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M., LaJoie D., Chen O.S., von Appen A., Ladinsky M.S., Redd M.J., Nikolova L., Bjorkman P.J., Sundquist W.I., Ullman K.S., et al. LEM2 recruits CHMP7 for ESCRT-mediated nuclear envelope closure in fission yeast and human cells. Proc. Natl. Acad. Sci. USA. 2017;114:E2166&#x2013;E2175. doi: 10.1073/pnas.1613916114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613916114</ArticleId><ArticleId IdType="pmc">PMC5358359</ArticleId><ArticleId IdType="pubmed">28242692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.R., Duan L., Bowen K., Kalab P., Rothstein J.D. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. eLife. 2020;9:e51685. doi: 10.7554/eLife.51685.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz S., Santarella-Mellwig R., Koch B., Jaedicke A., Mattaj I.W., Antonin W. NLS-mediated NPC functions of the nucleoporin Pom121. FEBS Lett. 2010;584:3292&#x2013;3298. doi: 10.1016/j.febslet.2010.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.07.008</ArticleId><ArticleId IdType="pubmed">20624389</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi T., Clever M., Watanabe A., Imamoto N. Localization of Pom121 to the inner nuclear membrane is required for an early step of interphase nuclear pore complex assembly. Mol. Biol. Cell. 2011;22:1058&#x2013;1069. doi: 10.1091/mbc.e10-07-0641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e10-07-0641</ArticleId><ArticleId IdType="pmc">PMC3069009</ArticleId><ArticleId IdType="pubmed">21289085</ArticleId></ArticleIdList></Reference><Reference><Citation>Borah S., Thaller D.J., Hakhverdyan Z., Rodriguez E.C., Isenhour A.W., Rout M.P., King M.C., Lusk C.P. Heh2/Man1 may be an evolutionarily conserved sensor of NPC assembly state. Mol. Biol. Cell. 2021;32:1359&#x2013;1373. doi: 10.1091/mbc.E20-09-0584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E20-09-0584</ArticleId><ArticleId IdType="pmc">PMC8694041</ArticleId><ArticleId IdType="pubmed">34010011</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidak S., Serebryannyy L.A., Misteli T. Activation of endoplasmic reticulum stress via clustering of inner nuclear membrane proteins. BioRixv. 2021 doi: 10.1101/2021.09.14.460295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.14.460295</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:182&#x2013;194. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., Clark C.M., Elman L.B., Miller B.L., Grossman M., et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008;173:182&#x2013;194. doi: 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosalaganti S., Kosinski J., Albert S., Schaffer M., Strenkert D., Salome P.A., Merchant S.S., Plitzko J.M., Baumeister W., Engel B.D., et al. In situ architecture of the algal nuclear pore complex. Nat. Commun. 2018;9:2361. doi: 10.1038/s41467-018-04739-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04739-y</ArticleId><ArticleId IdType="pmc">PMC6006428</ArticleId><ArticleId IdType="pubmed">29915221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerli C.E., Allegretti M., Rantos V., Goetz S.K., Obarska-Kosinska A., Zagoriy I., Halavatyi A., Hummer G., Mahamid J., Kosinski J., et al. Nuclear pores dilate and constrict in cellulo. Science. 2021;374:eabd9776. doi: 10.1126/science.abd9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd9776</ArticleId><ArticleId IdType="pubmed">34762489</ArticleId></ArticleIdList></Reference><Reference><Citation>Akey C.W., Singh D., Ouch C., Echeverria I., Nudelman I., Varberg J.M., Yu Z., Fang F., Shi Y., Wang J., et al. Comprehensive structure and functional adaptations of the yeast nuclear pore complex. BioRixv. 2021:1&#x2013;46. doi: 10.1016/j.cell.2021.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.015</ArticleId><ArticleId IdType="pubmed">34982960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamid J., Pfeffer S., Schaffer M., Villa E., Danev R., Cuellar L.K., Forster F., Hyman A.A., Plitzko J.M., Baumeister W. Visualizaing the molecular sociology at the HeLa cell nuclear periphery. Science. 2016;351:969&#x2013;972. doi: 10.1126/science.aad8857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8857</ArticleId><ArticleId IdType="pubmed">26917770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zila V., Margiotta E., Turonova B., Muller T.G., Zimmerli C.E., Mattei S., Allegretti M., Borner K., Rada J., Muller B., et al. Cone-shaped HIV-1 capsids are transported through intact nuclear pores. Cell. 2021;184:1032&#x2013;1046.e18. doi: 10.1016/j.cell.2021.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.025</ArticleId><ArticleId IdType="pmc">PMC7895898</ArticleId><ArticleId IdType="pubmed">33571428</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>